TABLE 3.
Multivariate analysis of pCR after neoadjuvant immunotherapy for locally advanced MSS/pMMR colorectal cancer patients in the training cohort.
| Variables | OR (95%CI) | P |
|---|---|---|
| Age (year) | 0.96 (0.93 ∼ 0.99) | 0.020 |
| Post-LogCEA | 0.19 (0.05 ∼ 0.70) | 0.013 |
| ΔGNRI | 1.07 (1.02 ∼ 1.12) | 0.006 |
OR, odds ratio; CI, confidence interval; Post-LogCEA, post–neoadjuvant treatment LogCEA. Bold values indicate P < 0.05, which is considered statistically significant.